Edition:
United Kingdom

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

28.72EUR
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
€28.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
688,398
52-wk High
€29.64
52-wk Low
€21.57

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.61
Market Cap(Mil.): €17,839.70
Shares Outstanding(Mil.): 687.55
Dividend: 0.15
Yield (%): 1.17

Financials

  GRLS.MC Industry Sector
P/E (TTM): 35.36 29.73 33.85
EPS (TTM): 0.83 -- --
ROI: 5.23 13.04 12.69
ROE: 14.00 14.12 17.13

Spain's Grifols, China's Shanghai RAAS form strategic alliance

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019

Spain's Grifols, China's Shanghai RAAS form strategic alliance

March 7 Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China.

07 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates